Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using <scp>GLOBOCAN</scp> 2020-Reference-Cited by-同舟云学术

Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020

Published:2022-03-30 Issue:9 Volume:151 Page:1535-1541
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Cabasag Citadel J.¹^ORCID,Fagan Paula J.¹²,Ferlay Jacques¹^ORCID,Vignat Jerome¹,Laversanne Mathieu¹,Liu Lihua³⁴,van der Aa Maaike A.⁵,Bray Freddie¹^ORCID,Soerjomataram Isabelle¹^ORCID

Affiliation:

1. Cancer Surveillance Branch, International Agency for Research on Cancer Lyon France

2. The Royal Marsden NHS Foundation Trust London UK

3. Norris Comprehensive Cancer Center, Keck School of Medicine University of Southern California Los Angeles California USA

4. Department of Population and Public Health Sciences, Keck School of Medicine University of Southern California Los Angeles California USA

5. Department of Research & Development Netherlands Comprehensive Cancer Organization (IKNL) Utrecht The Netherlands

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.34002

Reference26 articles.

1. The influence of birth cohort and calendar period on global trends in ovarian cancer incidence

2. International patterns and trends in ovarian cancer incidence, overall and by histologic subtype

3. Trends in hormone use and ovarian cancer incidence in US white and Australian women: implications for the future

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements;International Journal of Molecular Sciences;2024-02-03

2. Gynaecological cancer incidence and mortality trends in a Brazilian State with medium human development index: A 22-year analysis;Cancer Epidemiology;2024-02

3. Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment;Frontiers in Drug Delivery;2024-02-01

4. Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing;Pathology - Research and Practice;2024-02

5. Social integration and utilization of national basic public health services among China's internal migrants with chronic diseases: A structural equation modelling approach;Heliyon;2024-02